Immunovant Inc - Asset Resilience Ratio

Latest as of September 2019: 98.50%

Immunovant Inc (IMVT) has an Asset Resilience Ratio of 98.50% as of September 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IMVT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$116.02 Million

Cash + Short-term Investments

Total Assets

$117.79 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Immunovant Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Immunovant Inc.

Liquid Assets Composition Over Time

This chart breaks down Immunovant Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read IMVT current and long-term liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$116.02 Million	98.5%
Total Liquid Assets	$116.02 Million	98.50%

Asset Resilience Insights

Very High Liquidity: Immunovant Inc maintains exceptional liquid asset reserves at 98.50% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Immunovant Inc Industry Peers by Asset Resilience Ratio

Compare Immunovant Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Vaxcyte Inc NASDAQ:PCVX	Biotechnology	41.54%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	38.51%
Chongqing Zhifei Bio Products SHE:300122	Biotechnology	-0.08%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	2.30%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.12%

Annual Asset Resilience Ratio for Immunovant Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Immunovant Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Immunovant Inc

NASDAQ:IMVT USA Biotechnology

Market Cap

$7.51 Billion

Market Cap Rank

#2759 Global

#992 in USA

Share Price

$36.38

Change (1 day)

-0.74%

52-Week Range

$14.78 - $44.96

All Time High

$52.71